Skip to main content
NEW! The Investment Opportunity Report
The Investment Opportunity Report
Download Now

Looking For Our European Funds?

Click Here
About How To Invest
Ark Logo

Select Your Region

CONTINUE TO U.S. SITE VISIT EUROPEAN SITE
Mentioned Companies: GH, TSLA

May mARKet Update Webinar Summary

May 29, 2025
12 min read
By ARK Invest

In ARK Invest’s May mARKet Update Webinar, CEO and CIO Cathie Wood and members of the ARK Investment Team discussed key macroeconomic indicators, earnings season developments, and emerging signals from innovation platforms. The conversation included insights on interest rates, Bitcoin resilience, SpaceX’s valuation model, regulatory shifts in healthcare, and Tesla’s progress toward autonomy. Below is a summary of the team’s responses to investor-submitted questions. For further insights, please view the full May mARKet Update Webinar here.

What are your thoughts on the Fed’s recent interest rate decision? Do you expect any rate cuts later this year?

CEO and CIO Cathie Wood emphasized that the Federal Reserve appears focused on consumer inflation expectations and the potential inflationary impact of tariffs. However, ARK views tariffs more as tax increases than drivers of inflation. Wood cited Truflation, which leads CPI inflation by 45 days, as signaling continued disinflation. Combined with weak economic activity and potentially negative second-quarter GDP, ARK expects real interest rates to become unreasonably high, prompting multiple rate cuts before year-end.

From an investor’s perspective, how are you thinking about the timing of a potential rebound? Do inflation, rates, and emerging tariffs still pose meaningful short- to mid-term risks?

Cathie Wood highlighted recent trade negotiations that could reduce tariffs and eliminate non-tariff barriers, such as those recently relaxed in India and the UK. ARK views these developments as a global tax cut rather than a rise in protectionism. Wood suggested that markets may already be pricing in this shift, with risk assets rallying accordingly. She reiterated ARK’s long-held view that innovation is best accessed through regular, disciplined exposure rather than market timing.

What stood out to you in Tesla’s recent earnings call?

Daniel Maguire, ARK’s Autonomous Technology and Robotics Research Analyst, noted that Tesla confirmed its low-cost vehicle remains on track and that its commercial robotaxi service is expected to launch in Austin by June 2025. According to ARK’s models, up to 90% of Tesla’s enterprise value by 2029 could stem from its robotaxi business. Director of Research, Autonomous Technology and Robotics Sam Korus added that Tesla’s ability to produce 5,000 vehicles per day far exceeds the scalability of peers like Waymo. Tesla’s energy storage business also continues to gain traction. Wood reinforced that Tesla’s vertically integrated, cost-efficient approach gives it a structural advantage over competitors.

I saw your newsletter about a SpaceX model coming soon. Can you share a teaser? What’s the high-level thinking on SpaceX?

Daniel Maguire shared a preview of ARK’s forthcoming open-source SpaceX valuation model, built in collaboration with Mach 33. The model is based on a flywheel framework where revenue from Starlink fuels reinvestment into launch infrastructure and Mars-related R&D. As satellite bandwidth per kilogram increases, SpaceX’s margins and growth potential improve. Sam Korus added that ARK applied Wright’s Law to project cost declines across the stack. The model incorporates assumptions around capital efficiency, satellite performance, and long-term monetization of Mars-related capabilities.

With Guardant Health newly added to ARKK, what’s your latest thinking on the name?

Multiomics Research Analyst Nemo Marjanovic explained that Guardant Health is a leader in liquid biopsy diagnostics. Already the market leader in therapy selection, the company recently received FDA approval and Medicare coverage for the first blood-based screening test for colorectal cancer. Marjanovic noted promising data in multi-cancer detection and emphasized Guardant’s efforts to build a proprietary data moat. Cathie Wood added that blood tests for early cancer detection and recurrence monitoring could transform care models and patient outcomes.

Bitcoin has shown surprising strength during recent market volatility. What do you think is driving the move?

David Puell, Research Trading Analyst and Associate Portfolio Manager, Digital Assets, pointed to Bitcoin’s significant outperformance versus both the S&P 500 and the US dollar during April. Puell attributed this to institutional flows, including ETF-related demand, and a growing appreciation of bitcoin’s dual role as both a risk-on and risk-off asset. On-chain signals show more stability and less leverage than in past bull markets. Cathie Wood emphasized bitcoin’s resilience during recent tariff volatility as further evidence of underlying demand strength.

ARK does not hold any bitcoin mining stocks. What is the reasoning behind that?

ARK’s Director of Digital Assets, Lorenzo Valente, explained that mining is a capital-intensive business with limited margin control and exposure to regulatory and hardware supply chain risks. ARK views the risk-reward trade-off of mining unfavorably compared to holding bitcoin or investing in scalable, software-driven infrastructure. While ARK actively monitors the space, Valente underscored that the team currently favors companies with stronger network effects and less operational fragility.

This week we’ve seen notable federal appointments, including the new head of the Center for Biologics Evaluation and Research and the FDA’s first Chief AI Officer. What impact could these leadership changes have on healthcare?

Nemo Marjanovic emphasized that these appointments could accelerate the adoption of AI across the healthcare ecosystem. The FDA recently completed a pilot showing that AI reduced some review processes from three days to six minutes. The agency aims to expand AI integration by June. Marjanovic also praised the appointment of Vinay Prasad to the CBER, suggesting that his emphasis on rigorous, science-based evaluation will support the approval of curative over chronic therapies. Cathie Wood added that ARK expects the most profound applications of AI to emerge in healthcare and sees these regulatory changes as a pivotal moment for medical innovation.

Conclusion

The May webinar reflected ARK’s continued focus on long-term innovation trends despite near-term macroeconomic noise. From Tesla’s autonomy milestones to SpaceX’s capital-efficient growth engine and the transformative role of AI in both biotech and digital assets, ARK remains committed to investing in technologies poised to reshape the global economy. Stay tuned to our In The Know series and visit ark-funds.com for deeper insights.

Stay tuned to our In The Know video series for deeper insights about deflation, innovation, and macroeconomic developments.



Important Information

The information provided in this material is for informational purposes only and should not be used as the basis for any investment decision and is subject to change without notice. It does not constitute, either explicitly or implicitly, any provision of services or products by ARK, and investors should determine for themselves whether a particular investment management service is suitable for their investment needs. All statements made regarding companies or securities are strictly beliefs and points of view held by ARK and are not endorsements by ARK of any company or security or recommendations by ARK to buy, sell or hold any security. Historical results are not indications of future results. 

Certain of the statements contained in this material may be statements of future expectations and other forward-looking statements that are based on ARK's current views and assumptions and involve known and unknown risks and uncertainties that could cause actual results, performance or events to differ materially from those expressed or implied in such statements. ARK assumes no obligation to update any forward-looking information. ARK and its clients as well as its related persons may (but do not necessarily) have financial interests in securities or issuers that are discussed. Certain information was obtained from sources that ARK believes to be reliable; however, ARK does not guarantee the accuracy or completeness of any information obtained from any third party.

Bitcoin is a relatively new asset class, and the market for bitcoin is subject to rapid changes and uncertainty. Bitcoin is largely unregulated and bitcoin investments may be more susceptible to fraud and manipulation than more regulated investments. Bitcoin is subject to unique and substantial risks, including significant price volatility and lack of liquidity, and theft. 

Bitcoin is subject to rapid price swings, including as a result of actions and statements by influencers and the media, changes in the supply of and demand for bitcoin, and other factors. There is no assurance that bitcoin will maintain its value over the long term.

ARK strongly encourages any investor considering an investment in bitcoin or any other digital asset to consult with a financial professional before investing. All statements made regarding bitcoin are strictly beliefs and points of view held by ARK and are not recommendations by ARK to buy, sell or hold bitcoin. Historical results are not indications of future results.

To view the top ten holdings for ARKK click here.

To view the top ten holdings for ARKQ click here.

To view the top ten holdings for ARKW click here.

To view the top ten holdings for ARKG click here.

To view the top ten holdings for ARKF click here.

To view the top ten holdings for ARKX click here.

To view the top ten holdings for ARKVX click here.

ARK’s statements are not an endorsement of any company or a recommendation to buy, sell or hold any security. ARK and its clients as well as its related persons may (but do not necessarily) have financial interests in securities or issuers that are discussed. Certain of the statements contained may be statements of future expectations and other forward-looking statements that are based on ARK’s current views and assumptions and involve known and unknown risks and uncertainties that could cause actual results, performance, or events to differ materially from those expressed or implied in such statements.

Explore ARK Funds

Featured Funds:

ARKVX Icon

ARK Venture Fund

ARKQ Icon

ARK Autonomous Tech. & Robotics ETF

ARKW Icon

ARK Next Generation Internet ETF

ARKG Icon

ARK Genomic Revolution ETF

ARKK Icon

ARK Innovation ETF

ARKF Icon

ARK Fintech Innovation ETF

See All

Ready to Invest?

We believe all investors should have access to venture capital, cutting-edge research, impactful education, and a phenomenal user experience. Self-directed investors can download the SoFi App and get started today. Advisors can access ARKVX through Schwab, Fidelity, Pershing, and more!

Invest Now Here

ARK Trade Notifications

ARK offers fully transparent Exchange Traded Funds (“ETFs”) and provides investors with trade information for all actively managed ETFs.

ARK Invest logo
You Are Entering ark-funds.com

Please read this page before proceeding, as it explains certain restrictions imposed by law on the distribution of this information and the countries in which the funds are authorized for sale. By proceeding, you are confirming you understand that ARK Investment Management LLC or its affiliates (collectively, “ARK”), makes no representation that the content of the website is appropriate for use in all locations, or that the transactions, securities, products, instruments or services discussed at this website are available or appropriate for sale or use in all jurisdictions or countries, or by all investors or counterparties.


This section of the website is operated by ARK, and is only directed at U.S. investors or those otherwise authorized to conduct investment business in the U.S. Persons resident in territories other than the United States should not access this website.


It is your responsibility to be aware of and to observe all applicable laws and regulations of any relevant jurisdiction. Certain of the funds and advisory products and services referenced on this website may be managed or offered/provided by affiliates of ARK. Additionally, certain of the funds described in the following pages may be marketed in certain jurisdictions only. Any entity forwarding the material or information contained on this website, which is produced by ARK in the United States, to other parties takes full responsibility for ensuring compliance with applicable securities laws in connection with its distribution.


This website only includes information on those funds that are registered for sale in the United States.


By accessing this website, you are confirming that you agree to the Terms and Conditions of this website and that you are resident in the United States or those otherwise authorized to conduct investment business in the U.S.


The contents of this website have been prepared for informational purposes only without regard to the investment objectives, financial situation, or means of any particular person or entity, and ARK is not soliciting any action based upon them. No information included on this website is to be construed as investment advice or as a recommendation or a representation about the suitability or appropriateness of any fund; or an offer to buy or sell, or the solicitation of an offer to buy or sell, any security, financial product, or instrument; or to participate in any particular trading strategy. ARK recommends that you seek independent financial and tax advice before making any investment decisions. Investment in any of the funds described in this website should only be made on the basis of the terms and conditions of the most recent applicable offering documents (including any relevant supplements).


All material has been obtained from sources believed to be reliable, but its accuracy is not guaranteed. Some of the content on this website may contain certain statements that may be deemed forward-looking statements. Please note that any such statements are not guarantees of any future performance and actual results or developments may differ materially from those projected. From time to time, ARK may also make additional features available to users on this website on such terms and conditions as may be set forth in a modification to this Agreement or otherwise on the ARK website.


The ARK ETF Trust Thematic Actively Managed ETF’s are distributed by Foreside Fund Services, LLC (“Foreside“), which is not affiliated with ARK Investment Management LLC. Check the background of Foreside on FINRA’s BrokerCheck.


You should carefully consider the investment objective, risks, charges and expenses of a Fund before investing. A Fund’s prospectus and summary prospectus contain this and other important information about a Fund, which can be obtained by clicking the corresponding link or dialing the indicated phone number herein. Please read the appropriate prospectus carefully before investing.


GENERAL RISK FACTORS


You should be aware that past performance is not a reliable indicator of future performance. Please note that the price of units or shares and the income from them can fall as well as rise and you may not get back the amount originally invested. Income receivable may vary from the amount of income projected at the time of making the investment.


Exchange rate fluctuations may affect the value of an investment and any income derived from it.


If you exercise any right to redeem, you may not get back the amount initially invested if the unit or share price has fallen since you invested. Deductions for charges and expenses, particularly the initial charge (if any), are not made uniformly throughout the life of the investment, so if you redeem out of the investment during the early years, you may not get back the amount invested.


There can be no guarantee that the tax position or proposed tax position prevailing at the time of an investment will not change. Dividends and capital gains on securities issued in the relevant funds may be subject to withholding taxes imposed by the countries in which each particular fund invests.


The offering documents for the investment funds contain important information summarizing the relevant risk factors pertaining to the investment or relevant funds. Please note, however, that no summary of risk factors is exhaustive, and there may be other risks that could affect your investment. For your own benefit and protection you should read the most recent offering documents (including any relevant supplements) carefully before investing. If you do not understand any point please ask for further information.


The information provided on this website is not intended for distribution to, or use by, any person or entity in any jurisdiction or country where such distribution or use would be contrary to law or regulation, or which would subject any of the funds described herein, ARK (including its affiliates) or any of their products or services to any registration, licensing or other authorization requirement within such jurisdiction or country. Nothing on this website shall be considered a solicitation to buy or sell a security, product or service (including advisory service) to any person.


HYPERLINKS


ARK does not recommend or endorse and accepts no responsibility for the content of any website not operated by ARK which you may visit by following a link from this website. You acknowledge and agree that neither ARK nor any of its affiliates is responsible for the availability of such third-party websites or resources, does not endorse, approve, investigate or verify, and is not responsible or liable for any content, advertising, products, or other materials on or available from such websites or resources. You further agree that neither ARK nor any of its affiliates shall be responsible or liable, directly or indirectly, for any damage or loss caused or alleged to be caused by or in connection with use of or reliance on any such content, products or services available on such external websites or resources. These links are provided as a convenience and solely for informational purposes. ARK is not making any recommendation to invest in, purchase, or sell any securities or other products or services offered on the linked websites, nor has ARK sought to verify or confirm the information contained in the linked websites. Accordingly, ARK disclaims any responsibility for the linked websites.


No other website, without the prior written permission of ARK, is authorized to link to any part of this website.


COOKIES


ARK uses cookies for collecting user information from certain pages of this website. A cookie is a file that is stored on the hard disk of a computer by the web browser on a computer. It contains information sent by the website that a user has visited. A cookie identifies users and can store information about them and their use of a website. ARK uses cookies to keep track of user activity, which allows ARK to identify which areas of the website are more interesting to the users so that improvements can be made to this website.


ARK expressly reserves the right to monitor any use of this website.


I confirm that I have read and accept the Terms and Conditions of using this website and that I am based in the United States or those otherwise authorized to conduct investment business in the United States.